Mode
Text Size
Log in / Sign up

Liver injury

5 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for liver injury

2 trials tracked for liver injury: 1 in phase 3 or 4.

2Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 1 Phase 2 1
  1. Phase 3 Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation Completed
  2. Phase 2 Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about liver injury

Does the aryl hydrocarbon receptor cause liver injury through oxidative stress?

The aryl hydrocarbon receptor (AhR) can contribute to liver injury through oxidative stress, but it also protects the liver in other contexts, so its role is dual and depends on the trigger and the ligand involved [2].

Full answer →